Life science research instruments and clinical diagnostics products
Bio-Rad manufactures laboratory instruments and consumables for life science research and clinical diagnostics across a global operations network. The tech stack reveals a manufacturing-first engineering organization: embedded systems (ARM Cortex-M, CANopen, RS485) dominate alongside molecular biology platforms (qPCR, ddPCR), paired with enterprise systems (SAP, Veeva, Salesforce). Active hiring in manufacturing and operations—nearly 3x engineering—combined with a heavy pain-point focus on yield, downtime, and design-to-manufacturing transfer, signals an organization scaling production capacity and wrestling with operational efficiency.
Notable leadership hires: Manufacturing Director, Team Lead, Marketing Director
Bio-Rad is a publicly traded life sciences company operating since 1952 with approximately 8,000 employees across research and diagnostics divisions. The company supplies laboratory instruments, reagents, and consumables used by researchers and clinical labs to separate, identify, analyze, and amplify biological materials. Core products include qPCR and ddPCR systems, alongside diagnostic solutions for disease monitoring and treatment. Operations span 13 countries, with significant manufacturing and logistics footprint. Revenue model is primarily transactional—instrument sales paired with recurring consumables and reagents.
Bio-Rad has active hiring across 13 countries: United States, Germany, Hungary, India, Singapore, France, China, Canada, Japan, Switzerland, Netherlands, Brazil, and Australia.
Core stack includes embedded systems (ARM Cortex-M, CANopen, RS485, USB), molecular biology platforms (qPCR, ddPCR), enterprise software (SAP, Salesforce, Veeva Vault), business intelligence (Power BI, Essbase), and web technologies (Angular, TypeScript, WebAssembly, Electron). AWS is the primary cloud platform.
Other companies in the same industry, closest in size